This morning, Stryker (NYSE:SYK) announced it would acquire Mako Surgical (NASDAQ:MAKO) in a deal worth about $1.65 billion. Shareholders of Mako will receive $30 per share, a 86% premium over yesterday's closing value. Stryker said it expects the acquisition to be accretive to earnings after the second year. In trading on Wednesday, Mako Surgical surged to just below the buyout price, while Stryker fell by about 1.7%.
Any ideas and opinions presented in all Market News Video clips are for informational and educational purposes
only, and do not reflect the opinions of BNK Invest, Inc. or any of its affiliates, subsidiaries or partners.
In no way should any content contained herein be interpreted to represent trading or investment advice.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. Read Full Disclaimer.